McKinsey: AI could add $60B-$110B in annual value to pharma
HealthcareAIGuy · x · 2026-09-21
McKinsey estimates AI could generate $60B–$110B in annual economic value for the pharma and medical products industry. The value comes largely from accelerating drug discovery, speeding development and approval cycles, and improving how drugs are marketed.
Related event: McKinsey: AI Could Generate Up to $110B Annually for Pharma(2 posts)→
More from Venture
- King Slide: from cabinet handles to $43B AI supply chain winner, up 3,000% in 4 years — CatAstro_Piyush · 2026-09-22
- What happens to Amazon's ad business when AI agents do the comparison shopping? — firstadopter · 2026-09-22
- AMD Officially Crosses $1 Trillion Market Cap Milestone — Beth_Kindig · 2026-09-22
- Investor: humanoid robots' real TAM is retail, hospitality and schools — not the hype — MatthewChang · 2026-09-22
- SoftBank to acquire Marc Raibert's Robotics and AI Institute from Hyundai — lukas_m_ziegler · 2026-09-22
- Vercel at $500M+ Run-Rate With 130% Growth Ahead of Summit Fireside Chat — GavinSBaker · 2026-09-22